Ann Wiegand The virology Core at the HIV Drug Resistance Program NCI-Frederick Biography Publications Institution JoVE Articles Ann Wiegand has not added a biography. If you are Ann Wiegand and would like to personalize this page please email our Author Liaison for assistance. Publications Restricted Replication of Xenotropic Murine Leukemia Virus-Related Virus in Pigtailed Macaques Journal of Virology. Jan, 2012 | Pubmed ID: 22238316 No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1-Infected Patients Receiving Antiretroviral Therapy Journal of Acquired Immune Deficiency Syndromes (1999). Mar, 2012 | Pubmed ID: 22083073 Clonal Sequences Recovered from Plasma from Patients with Residual HIV-1 Viremia and on Intensified Antiretroviral Therapy Are Identical to Replicating Viral RNAs Recovered from Circulating Resting CD4+ T Cells Journal of Virology. May, 2011 | Pubmed ID: 21367910 HIV-1 Continues to Replicate and Evolve in Patients with Natural Control of HIV Infection Journal of Virology. Dec, 2010 | Pubmed ID: 20926564 The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-infected Patients on Antiretroviral Therapy: a Randomized Controlled Trial PLoS Medicine. 2010 | Pubmed ID: 20711481 Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection PloS One. 2010 | Pubmed ID: 20186346 Low Frequency Nonnucleoside Reverse-transcriptase Inhibitor-resistant Variants Contribute to Failure of Efavirenz-containing Regimens in Treatment- Experienced Patients The Journal of Infectious Diseases. Mar, 2010 | Pubmed ID: 20102272 Persistent Low-level Viremia in HIV-1 Elite Controllers and Relationship to Immunologic Parameters The Journal of Infectious Diseases. Sep, 2009 | Pubmed ID: 19656066 Evaluation of the Pathogenesis of Decreasing CD4(+) T Cell Counts in Human Immunodeficiency Virus Type 1-infected Patients Receiving Successfully Suppressive Antiretroviral Therapy The Journal of Infectious Diseases. Jun, 2009 | Pubmed ID: 19432547 Regimen Simplification to Atazanavir-ritonavir Alone As Maintenance Antiretroviral Therapy: Final 48-week Clinical and Virologic Outcomes The Journal of Infectious Diseases. Mar, 2009 | Pubmed ID: 19191590 Lytic Granule Loading of CD8+ T Cells is Required for HIV-infected Cell Elimination Associated with Immune Control Immunity. Dec, 2008 | Pubmed ID: 19062316 Valproic Acid Without Intensified Antiviral Therapy Has Limited Impact on Persistent HIV Infection of Resting CD4+ T Cells AIDS (London, England). Jun, 2008 | Pubmed ID: 18525258 Low-level Viremia Persists for at Least 7 Years in Patients on Suppressive Antiretroviral Therapy Proceedings of the National Academy of Sciences of the United States of America. Mar, 2008 | Pubmed ID: 18332425 ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia PLoS Pathogens. Apr, 2007 | Pubmed ID: 17411338 Depletion of Latent HIV-1 Infection in Vivo: a Proof-of-concept Study Lancet. Aug 13-19, 2005 | Pubmed ID: 16099290 New Real-time Reverse Transcriptase-initiated PCR Assay with Single-copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma Journal of Clinical Microbiology. Oct, 2003 | Pubmed ID: 14532178 Усиление и Количественная РНК ВИЧ-1 у ВИЧ-инфицированных с вирусной нагрузки ниже предела обнаружения стандартными клиническими Анализы Helene Mens1, Mary Kearney1, Ann Wiegand1, Jonathan Spindler1, Frank Maldarelli1, John W. Mellors2, John M. Coffin3 1The virology Core at the HIV Drug Resistance Program, NCI-Frederick, 2Division of Infectious Diseases, University of Pittsburgh, 3Department of Molecular Biology and Microbiology, Tuffts University JoVE 2960 Immunology and Infection
Усиление и Количественная РНК ВИЧ-1 у ВИЧ-инфицированных с вирусной нагрузки ниже предела обнаружения стандартными клиническими Анализы Helene Mens1, Mary Kearney1, Ann Wiegand1, Jonathan Spindler1, Frank Maldarelli1, John W. Mellors2, John M. Coffin3 1The virology Core at the HIV Drug Resistance Program, NCI-Frederick, 2Division of Infectious Diseases, University of Pittsburgh, 3Department of Molecular Biology and Microbiology, Tuffts University JoVE 2960 Immunology and Infection
